tongue neoplasm: A neoplasm (disease) that involves the tongue.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
986 |
4. Check minimum number of eventsNone |
986 |
5. Include endpointsNone |
986 |
6. Filter based on genotype QC (FinnGen only) |
986 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum linguae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Tongue
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Tongue
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6857 | 3760 | 3044 |
| Only index persons | 6202 | 3455 | 2747 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.11 | 0.09 |
| Only index persons | 0.12 | 0.13 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 57.60 | 58.88 | 56.04 |
| Only index persons | 57.19 | 58.39 | 55.69 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 986 | 561 | 425 |
| Unadjusted period prevalence (%) | 0.19 | 0.19 | 0.19 |
| Median age at first event (years) | 57.83 | 56.69 | 59.32 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 884
- Matched controls
- 8841
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.19
ICD-10 Finland
Benign tumor of the tongue UNS
+∞
323.0
413
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
60.5
266.4
310
78
D10.12
ICD-10 Finland
Bone tumor of the tip of the tongue
+∞
191.8
177
*
D10.10
ICD-10 Finland
Benign tumor at the base of the tongue
+∞
167.1
155
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
191.9
155.2
158
10
D10.11
ICD-10 Finland
Benign tumor in the back of the tongue
+∞
79.4
75
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
50.5
58.3
70
15
D10.1
ICD-10 Finland
Benign neoplasm: Tongue
+∞
55.8
53
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
181.9
34.0
35
*
8070/3-C02.1
ICD-O-3
Squamous cell carcinoma, NOS, of border of tongue
93.7
33.0
36
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
18.0
32.7
51
30
21010
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Tongue
+∞
30.4
29
*
EJB40
NOMESCO Finland
Hemiglossectomy
110.5
29.8
32
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
15.2
29.5
49
34
D10.14
ICD-10 Finland
Lingual tonsil
155.0
28.8
30
*
D20
ICPC
Mouth/tongue/lip symptom/complaint
5.2
25.1
81
169
K14.9
ICD-10 Finland
Disease of tongue, unspecified
53.5
22.2
26
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
21.9
392
2476
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
10.7
21.8
42
41
A07AA02
ATC
nystatin; oral
3.6
21.7
102
305
SAA03
NOMESCO Finland
Extended examination of mouth
2.1
21.6
361
2215
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.2
21.0
82
208
K13.29
ICD-10 Finland
Indefinite leukoplakia
14.5
21.0
35
25
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
20.0
20.9
31
16
EJB20
NOMESCO Finland
Excision of lesion of base of tongue
112.7
20.6
22
*
D10.13
ICD-10 Finland
Benign tumor under the tongue
+∞
19.9
19
*
UJC01
NOMESCO Finland
Scopy of lower throat
11.0
19.0
36
34
R13
ICD-10 Finland
Dysphagia
3.7
18.9
87
256
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
18.8
18
*
K14.61
ICD-10 Finland
Glossodynia
13.5
17.5
30
23
WX110
NOMESCO Finland
Local anesthesy
1.9
17.4
608
4750
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.6
17.1
80
238
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
17.1
319
1995
Z2221
NOMESCO Finland
Medical doctor
2.0
16.8
269
1586
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
16.0
269
1610
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
12.6
15.4
27
22
SXA10
NOMESCO Finland
Epithel biopsy of mouth
8.9
15.3
32
37
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
13.3
15.2
26
20
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.8
15.1
65
181
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
15.4
14.9
24
16
C02.9
ICD-10 Finland
Malignant neoplasm: Tongue, unspecified
57.7
14.8
17
*
2101A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Tongue
+∞
14.6
14
*
C02.10
ICD-10 Finland
Malignant neoplasm of tip of tongue
81.5
14.6
16
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.3
14.5
74
237
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.0
13.8
220
1280
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.9
13.4
82
297
ENA10
NOMESCO Finland
Biopsy of pharynx
21.5
13.4
19
9
A01AB09
ATC
miconazole; local oral
2.5
13.2
105
444
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.0
13.1
79
282
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
12.5
266
1704
A02BC05
ATC
esomeprazole; systemic
1.7
12.1
357
2521
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.6
12.1
54
156
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
27.1
12.1
16
6
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
47.3
11.9
14
*
J01DB01
ATC
cefalexin; oral
1.8
11.9
705
6060
A02BC02
ATC
pantoprazole; systemic
1.7
11.7
567
4578
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
11.6
389
2838
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
11.3
94
409
GBB00
NOMESCO Finland
Tracheostomy
6.0
11.3
30
51
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.2
11.1
29
48
K02.1
ICD-10 Finland
Caries of dentine
1.6
11.1
472
3656
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.5
10.9
89
383
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
10.6
352
2544
J02AC01
ATC
fluconazole; systemic
1.7
10.5
328
2327
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.0
10.2
59
207
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
10.0
581
4810
ZXC10
NOMESCO Finland
Use of laser
4.2
10.0
37
91
N06AX11
ATC
mirtazapine; oral
1.7
10.0
272
1852
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.7
9.9
22
29
8070/3-C02.9
ICD-O-3
Squamous cell carcinoma, NOS, of tongue, NOS
20.3
9.8
14
7
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.6
9.8
394
2971
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
9.8
190
1169
EDB00
NOMESCO Finland
Partial excision of mandible
55.6
9.7
11
*
WF002
NOMESCO Finland
Radical radiotherapy
3.0
9.5
55
193
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
9.5
271
1864
130
Kela drug reimbursment
Malignant tumour
2.3
9.3
86
393
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
9.3
239
1598
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
3.9
9.2
36
94
ZXE00
NOMESCO Finland
One hour or less
1.6
9.2
336
2465
K13.78
ICD-10 Finland
Other change in the oral mucosa
4.4
9.2
32
75
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
37.1
9.0
11
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
9.6
8.8
17
18
N02BE01
ATC
paracetamol; systemic, rectal
1.7
8.8
744
6661
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
8.8
47
158
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
16.5
8.6
13
8
D02
ICPC
Abdominal pain epigastric
2.7
8.4
55
211
N05BA04
ATC
oxazepam; oral
1.7
8.4
217
1449
C02.1
ICD-10 Finland
Malignant neoplasm: Border of tongue
+∞
8.3
8
*
4399
FHL
Other measure in this category
+∞
8.3
8
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.3
211
1401
R4110
NOMESCO Finland
Physiotherapy
1.6
8.3
230
1565
J01FA10
ATC
azithromycin; systemic
1.5
8.2
463
3722
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
8.2
290
2096
N05CF01
ATC
zopiclone; oral
1.6
8.2
281
2016
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
11.8
8.1
14
12
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
33.7
8.1
10
*
S29
ICPC
Skin symptom/complaint other
1.8
8.1
150
907
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
8.0
450
3607
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.6
8.0
298
2177
D07AC13
ATC
mometasone; topical
1.6
8.0
239
1655
WX402
NOMESCO Finland
General anaesthesia
1.8
7.9
142
849
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
7.9
427
3394
Z01.9
ICD-10 Finland
Special examination, unspecified
2.6
7.9
57
230
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.8
197
1304
N02AA05
ATC
oxycodone; systemic
1.8
7.7
134
791
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
7.7
509
4207
ZX095
NOMESCO Finland
Combined chemoradiotherapy
12.0
7.6
13
11
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.3
7.4
35
108
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
7.4
169
1082
4392
FHL
Tongue and / or Mouth resection or excision
80.7
7.4
8
*
EJB00
NOMESCO Finland
Excision of ranula
80.7
7.4
8
*
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
+∞
7.3
7
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
7.3
100
543
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
7.3
312
2344
EBA10
NOMESCO Finland
Surgical removal of tooth
2.0
7.2
92
487
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
7.2
171
1111
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
30.3
7.2
9
*
K13.2
ICD-10 Finland
Leukoplakia and other disturbances of oral epithelium, including tongue
20.2
7.1
10
5
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
7.1
56
238
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
7.1
206
1409
R01AD09
ATC
mometasone; nasal
1.5
7.1
350
2708
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
7.0
100
552
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.5
7.0
52
214
S18
ICPC
Laceration/cut
1.5
6.9
352
2737
SBA00
NOMESCO Finland
Microbiological examinations
3.3
6.9
33
104
R01AD08
ATC
fluticasone; nasal
1.6
6.8
227
1605
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.5
6.8
328
2519
K14.09
ICD-10 Finland
Glossit UNS
40.3
6.8
8
*
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
40.3
6.8
8
*
K14.5
ICD-10 Finland
Plicated tongue
16.8
6.8
10
6
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
6.5
6.7
16
25
UJF32
NOMESCO Finland
Coloscopy
1.6
6.6
214
1501
L14
ICPC
Leg/thigh symptom/complaint
2.2
6.5
67
324
D10.2
ICD-10 Finland
Benign neoplasm: Floor of mouth
70.3
6.4
7
*
A02BC01
ATC
omeprazole; systemic
1.5
6.4
229
1642
J01MA12
ATC
levofloxacin; systemic
1.6
6.4
155
1011
UJD02
NOMESCO Finland
Gastroscopy
2.5
6.4
48
199
K05.31
ICD-10 Finland
Periodontitis pronounced
1.9
6.4
91
502
L02
ICPC
Back symptom/complaint
2.0
6.3
73
372
Z50.5
ICD-10 Finland
Speech therapy
6.0
6.3
16
27
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.3
546
4674
C02.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of tongue
+∞
6.3
6
*
C02.0
ICD-10 Finland
Malignant neoplasm: Dorsal surface of tongue
26.9
6.2
8
*
K14.88
ICD-10 Finland
Other diseases of tongue
26.9
6.2
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.6
6.2
153
1003
B37.0
ICD-10 Finland
Candidal stomatitis
6.3
6.2
15
24
Z2446
NOMESCO Finland
Social worker
2.2
6.2
60
282
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.2
334
2614
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
6.1
133
841
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
6.1
67
333
E0000UV
ATC
NA
1.5
6.1
309
2383
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.1
347
2739
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.1
223
1607
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.7
6.1
12
14
R03BA05
ATC
fluticasone; inhalant
1.6
6.0
144
933
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.7
6.0
37
139
N06AA09
ATC
amitriptyline; systemic
1.9
6.0
90
506
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
562
3249
2.70
50.43
2.7
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
514
3692
1.82
18.60
7.5
5.9
%
0.7
0.7
0.05
477
3451
(3013115) Eosinophils [#/volume] in Blood
565
4195
1.81
18.13
7.1
6.0
e9/l
0.2
0.2
0.06
495
3694
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
583
4371
1.82
18.10
7.4
6.3
umol/l
11.2
11.2
0.04
545
4141
(3026389) Candida sp identified in Specimen by Organism specific culture
43
97
4.59
17.90
2.3
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
772
6337
2.01
17.87
9.9
7.7
u/l
78.2
78.7
0.17
728
5949
(3006504) Eosinophils/100 leukocytes in Blood
523
3810
1.79
17.74
7.5
5.9
%
2.7
2.9
0.60
484
3552
(3019069) Monocytes/100 leukocytes in Blood
524
3826
1.79
17.58
7.8
6.1
%
8.8
8.7
0.28
487
3591
(3001604) Monocytes [#/volume] in Blood
547
4045
1.79
17.57
7.0
5.7
e9/l
0.6
0.6
0.19
471
3498
(3006315) Basophils [#/volume] in Blood
547
4065
1.78
17.08
7.0
5.7
e9/l
0.0
0.0
0.26
471
3525
(3002030) Lymphocytes/100 leukocytes in Blood
530
3907
1.77
16.98
7.7
6.0
%
26.5
27.7
1.49
491
3650
(42870588) Differential panel, method unspecified - Blood
403
2746
1.79
16.92
7.1
5.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
490
3548
1.76
16.56
5.8
4.8
g/l
35.4
35.4
0.07
455
3292
(3019198) Lymphocytes [#/volume] in Blood
551
4145
1.75
16.10
7.1
5.7
e9/l
1.8
1.9
0.48
483
3653
(3018010) Neutrophils/100 leukocytes in Blood
520
3849
1.74
16.09
7.4
5.7
%
57.9
57.3
0.49
483
3612
(3033658) Prothrombin time (PT) actual/Normal
318
2045
1.82
16.01
4.4
3.8
%
92.1
90.4
0.54
312
1999
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
546
4106
1.74
15.89
8.0
6.7
mmol/l
1.2
1.2
0.26
461
3487
(3013650) Neutrophils [#/volume] in Blood by Automated count
607
4719
1.74
15.52
11.5
9.1
e9/l
4.1
4.1
0.18
534
4150
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
503
3769
1.68
14.22
7.0
5.9
mmol/l
1.2
1.2
0.21
448
3406
(4035726)
147
756
2.11
14.16
1.6
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
170
924
2.01
14.10
3.1
2.7
umol/l
9.0
8.4
0.11
143
812
(3031040) Bacteria [#/volume] in Urine by Automated count
662
5368
1.71
13.59
5.6
4.5
e6/l
2923.3
2941.2
0.00
14
89
(3002582) Erythrocytes [#/volume] in Urine
356
2489
1.67
12.72
3.4
3.3
e6/l
236.7
82.2
0.35
258
1928
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
143
763
2.02
12.41
2.6
2.4
u/l
32.7
40.3
0.63
120
644
(3018418) pH of Serum or Plasma
348
2433
1.67
12.36
5.0
4.1
ph
7.4
7.4
0.24
56
456
(3037467) Urinalysis macro (dipstick) panel - Urine
680
5622
1.68
12.27
5.3
4.4
—
—
—
0
0
(3002256) Pathology report gross observation
176
1013
1.90
12.24
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
216
1327
1.80
12.20
2.9
2.9
e6/l
1.4
2.3
1.81
116
723
(3013826) Glucose [Moles/volume] in Serum or Plasma
603
4841
1.63
12.18
5.7
4.7
mmol/l
6.7
6.7
0.00
576
4541
(3023368) Bacteria identified in Blood by Culture
326
2248
1.67
12.17
5.1
4.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
400
2907
1.63
12.13
4.2
3.8
e6/l
48.1
100.3
1.99
280
2081
(3030467) Casts [#/volume] in Urine by Automated count
331
2293
1.67
12.13
3.4
3.1
e6/l
0.3
0.4
1.54
236
1735
(40768797) Stomach Pathology biopsy report
196
1184
1.82
11.66
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
301
2066
1.66
11.28
8.6
6.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
18
28
6.53
11.12
3.0
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
716
6074
1.65
10.92
4.7
4.1
mm/h
13.1
12.6
0.38
651
5600
(3012095) Magnesium [Moles/volume] in Serum or Plasma
214
1352
1.74
10.86
5.0
3.2
mmol/l
0.8
0.8
1.30
200
1263
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
222
1421
1.73
10.74
2.8
2.7
e6/l
0.7
1.1
2.73
123
816
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
91
433
2.21
10.61
7.5
9.8
mmol/l
25.0
24.5
1.05
86
405
(36304419) Bacteria [Presence] in Urine
314
2206
1.62
10.61
3.4
3.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
239
1568
1.69
10.54
3.8
3.8
ng/l
379.8
404.8
0.05
185
1226
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
359
2621
1.58
10.25
4.0
3.2
u/l
32.9
32.4
0.07
331
2494
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
115
608
2.01
10.18
2.0
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
170
1029
1.79
9.94
1.6
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
888
8077
2.00
9.80
22.2
14.5
mg/l
27.5
24.0
1.73
735
6405
(3015377) Calcium [Moles/volume] in Serum or Plasma
380
2837
1.55
9.71
4.8
3.4
mmol/l
2.4
2.4
0.69
327
2462
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
443
3423
1.53
9.67
2.3
2.0
pmol/l
95.7
95.5
0.03
200
1757
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
282
1978
1.60
9.40
2.9
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
717
6198
1.57
8.99
4.6
3.9
pmol/l
14.8
14.9
0.31
647
5604
(3014111) Lactate [Moles/volume] in Serum or Plasma
129
747
1.84
8.68
6.8
6.6
mmol/l
1.3
1.4
0.44
122
715
(3019550) Sodium [Moles/volume] in Serum or Plasma
910
8425
2.04
8.36
24.0
16.8
mmol/l
139.4
139.7
2.87
891
8210
(3001122) Ferritin [Mass/volume] in Serum or Plasma
430
3389
1.48
8.07
3.2
2.7
ug/l
132.0
133.8
0.05
398
3108
(3032080) INR in Blood by Coagulation assay
431
3405
1.47
7.95
9.7
9.4
inr
1.2
1.3
0.72
113
966
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
172
1108
1.67
7.94
2.6
2.4
%
21.4
22.8
0.57
153
958
(3023103) Potassium [Moles/volume] in Serum or Plasma
910
8451
2.00
7.88
24.4
16.9
mmol/l
3.9
4.0
2.56
888
8223
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
426
3368
1.47
7.78
2.6
2.2
nmol/l
79.4
77.6
0.57
375
2988
(3044640) Blood type and Crossmatch panel - Blood
342
2596
1.49
7.65
3.2
2.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
345
2628
1.48
7.56
2.7
2.5
u/l
55.8
56.4
0.07
310
2426
(3036481) Cortisol [Moles/volume] in Serum or Plasma
126
757
1.76
7.48
2.9
2.1
nmol/l
380.5
374.0
0.12
108
693
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
50
216
2.39
7.34
3.1
2.9
mg/l
1.3
1.6
1.77
45
197
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
278
2039
1.51
7.30
2.7
2.1
mg/l
2.7
3.1
1.79
233
1737
(3018677) aPTT in Platelet poor plasma by Coagulation assay
189
1275
1.60
7.22
1.9
2.0
s
29.8
29.6
0.24
183
1229
(3004789) Transferrin [Mass/volume] in Serum or Plasma
178
1184
1.61
7.20
2.5
2.3
g/l
2.3
2.3
0.04
165
1105
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
223
1565
1.55
7.17
4.0
3.1
mmol/l
2.5
2.5
0.84
197
1369
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
820
7439
1.61
7.13
5.7
4.7
mu/l
1.9
2.1
0.46
745
6768
(3022217) INR in Platelet poor plasma by Coagulation assay
164
1074
1.63
7.06
25.3
24.8
inr
1.3
1.3
0.09
23
138
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
471
3846
1.43
7.00
4.5
3.9
—
—
—
0
0
(3026782) Osmolality of Urine
229
1627
1.53
6.94
3.2
2.8
mosm/kgh2o
531.9
550.6
0.61
185
1394
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
330
2530
1.46
6.86
2.2
2.1
u/l
185.4
250.4
0.81
311
2384
(3000850) Epithelial cells [#/volume] in Urine
239
1718
1.52
6.85
2.7
2.6
e6/l
5.5
6.1
0.25
197
1525
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
145
928
1.66
6.82
5.0
4.2
u/l
245.8
247.0
0.02
140
874
(3042936) Bacteria identified in Isolate by Culture
178
1207
1.58
6.61
2.4
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1986
1.48
6.59
1.8
1.6
nmol/l
22.6
20.9
1.13
220
1673
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
73
385
1.97
6.53
3.4
3.5
mmol/l
25.4
24.2
2.20
67
346
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
195
1356
1.55
6.48
2.1
1.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
52
245
2.18
6.27
2.8
3.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
556
4730
1.40
6.26
3.0
2.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
40
169
2.42
6.20
1.4
1.4
u/l
12.9
10.5
0.40
35
133
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
175
1202
1.55
6.12
1.5
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
185
1288
1.54
6.09
2.6
2.3
umol/l
12.5
13.0
0.41
169
1188
(3021589) Normoblasts [#/volume] in Blood
437
3589
1.39
5.96
12.1
9.7
e9/l
0.0
0.0
0.68
357
2945
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
442
1.86
5.94
2.7
3.4
pmol/l
4.5
4.5
0.09
69
379
(3000991) Gas panel - Venous blood
111
690
1.69
5.83
8.3
8.0
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
11
20
5.55
5.81
2.0
1.3
ug/l
0.2
0.4
—
6
12
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
144
958
1.59
5.78
2.0
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
116
736
1.65
5.63
7.3
6.7
mmol/l
8.5
9.8
1.38
110
698
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
86
506
1.77
5.50
2.0
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
124
807
1.61
5.45
2.9
2.2
g/l
0.2
0.2
1.30
115
752
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
834
7711
1.53
5.44
20.3
13.5
ml/min/173m2
80.0
79.6
0.25
708
6364
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
45
213
2.17
5.40
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
913
8631
1.78
5.40
13.9
10.7
u/l
25.8
26.4
0.66
885
8315
(3017446) Testosterone [Moles/volume] in Serum or Plasma
92
556
1.72
5.36
2.4
2.2
nmol/l
13.0
12.9
0.04
82
493
(3048689) Calprotectin [Mass/mass] in Stool
141
950
1.57
5.35
2.4
2.2
ug/g
153.8
133.3
0.20
107
755
(3021601) Nitrite [Presence] in Urine by Test strip
475
4004
1.36
5.30
5.9
5.2
estimate
0.0
0.0
0.00
84
757
(3008295) Osmolality of Serum or Plasma
26
96
2.75
5.30
1.4
1.4
mosm/kgh2o
284.5
277.1
0.96
19
66
(3022145) Colonoscopy Study observation
140
944
1.56
5.29
1.4
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
477
4045
1.35
5.03
4.2
3.8
estimate
0.0
0.0
0.80
81
731
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
240
1822
1.42
5.03
1.9
1.6
mg/l
1.1
1.2
0.10
184
1397
(3011397) Hemoglobin [Presence] in Urine by Test strip
246
1876
1.41
5.02
3.7
3.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
36
3.93
5.00
4.7
4.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
791
7270
1.45
4.99
23.6
15.7
%
39.5
39.7
0.15
580
5109
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
855
7981
1.54
4.97
5.3
4.7
mmol/l
6.0
6.0
0.01
763
7238
(3013139) Helicobacter pylori Ag [Presence] in Stool
85
514
1.72
4.95
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
209
1554
1.44
4.90
1.9
1.7
nmol/l
1151.6
1215.1
0.37
144
1150
(3027945) Reticulocytes/100 erythrocytes in Blood
135
921
1.54
4.84
2.9
2.7
%
1.8
1.8
0.20
116
827
(3035350) Ketones [Presence] in Urine by Test strip
469
3985
1.34
4.80
4.2
3.8
estimate
0.0
0.0
0.00
82
751
(3019225) pH of Specimen
125
840
1.56
4.80
4.9
4.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
140
966
1.52
4.77
2.0
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
118
784
1.57
4.76
3.8
3.3
mmol/l
2.6
2.0
0.99
106
620
(3007164) IgA [Mass/volume] in Serum or Plasma
209
1563
1.43
4.73
1.5
1.5
g/l
2.4
2.5
0.26
112
951
(3000492) Spirometry study
115
761
1.58
4.72
1.7
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
84
515
1.69
4.66
1.4
1.4
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
155
1098
1.49
4.65
7.1
5.4
mmol/l
1.0
1.0
0.29
150
1008
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
25
98
2.59
4.58
3.0
3.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
105
685
1.60
4.57
2.8
2.7
e9/l
74.0
72.3
0.18
71
522
(40768795) Lymph node Pathology biopsy report
22
81
2.76
4.53
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
142
2.30
4.51
1.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
891
8429
1.59
4.48
19.1
13.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
737
6733
1.37
4.46
26.5
18.8
g/l
331.8
332.3
0.79
729
6680
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
94
2.59
4.41
1.2
1.2
u/l
52.7
50.7
0.08
18
70
(3002385) Erythrocyte distribution width [Ratio]
733
6698
1.37
4.38
25.9
17.8
%
13.8
13.7
0.50
722
6552
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
600
5328
1.32
4.32
3.9
3.2
u/l
51.9
51.4
0.04
548
4954
(3017143) Hepatitis C virus Ab [Presence] in Serum
119
810
1.53
4.32
1.7
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
149
1066
1.47
4.25
7.7
6.7
mmol/l
104.3
104.2
0.19
142
1038
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
225
1735
1.38
4.24
1.3
1.2
u/ml
0.7
1.4
1.86
58
464
(3044889) 12 lead EKG panel
650
5851
1.33
4.18
4.2
3.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
306
2486
1.33
4.10
3.0
3.0
ng/l
1257.9
1217.6
0.07
266
2110
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
7
10.06
4.01
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
136
967
1.47
4.00
7.1
7.4
mmol/l
1.0
1.2
0.13
113
767
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
38
3.45
3.91
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
38
3.45
3.91
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
131
930
1.47
3.89
2.4
1.8
%
1.6
1.5
0.24
110
810
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
46
250
1.88
3.86
2.3
2.6
u/ml
0.3
0.4
0.22
20
145
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
121
854
1.48
3.70
3.5
3.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
34
169
2.05
3.68
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
34
169
2.05
3.68
1.6
1.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
933
8983
1.72
3.67
30.7
21.3
fl
91.3
91.2
0.45
921
8838
(46235355) HIV 1 and 2 tests - Meaningful Use set
152
1122
1.42
3.67
1.9
1.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
933
8984
1.72
3.66
30.6
21.3
pg
30.4
30.3
0.16
921
8838
(3026361) Erythrocytes [#/volume] in Blood
933
8985
1.71
3.64
30.8
21.4
e12/l
4.4
4.5
2.17
911
8724
(3010813) Leukocytes [#/volume] in Blood
933
8986
1.71
3.63
30.9
21.4
e9/l
6.8
6.7
0.33
911
8722
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
134
969
1.44
3.62
7.2
7.4
kpa
5.2
5.1
0.36
127
930
(3027801) Oxygen [Partial pressure] in Arterial blood
134
969
1.44
3.62
7.2
7.4
kpa
12.5
12.1
0.34
126
933
(3000963) Hemoglobin [Mass/volume] in Blood
933
8988
1.71
3.60
31.0
21.5
g/l
133.3
135.2
3.35
921
8842
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
213
1.92
3.58
1.5
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
59
355
1.70
3.56
2.1
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
130
938
1.44
3.55
2.0
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
932
8981
1.69
3.52
30.8
21.4
e9/l
249.6
249.3
0.05
914
8743
(40768443) Skin Pathology biopsy report
59
359
1.68
3.43
1.4
1.2
—
—
—
0
0
(4010399)
89
599
1.53
3.43
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
42
3.12
3.38
2.1
2.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
248
1.81
3.33
1.5
1.5
ug/g
253.6
284.8
0.49
26
147
(3017732) Neutrophils [#/volume] in Blood
82
554
1.52
3.12
3.3
3.1
e9/l
3.9
4.1
0.24
56
418
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
61
387
1.61
3.04
1.8
1.9
g/l
1.6
1.5
0.25
51
338
(3022621) pH of Urine by Test strip
80
543
1.52
2.99
2.8
2.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
12
40
3.02
2.98
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
141
2.01
2.97
2.1
2.0
%
60.5
62.1
0.13
28
141
(3026008) Bacteria identified in Urine by Culture
299
2517
1.27
2.92
3.7
3.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
83
2.31
2.85
1.9
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
33
179
1.87
2.85
2.5
2.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
24
116
2.10
2.84
3.1
2.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
953
1.38
2.80
1.5
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
14
53
2.67
2.80
1.1
1.5
—
217.5
—
0
8
(3024980) IgG subclass 4 [Mass/volume] in Serum
24
117
2.08
2.79
2.3
1.7
g/l
0.8
0.9
0.03
19
91
(3000475) Leukocytes [#/volume] in Synovial fluid
37
210
1.79
2.78
2.0
1.7
e6/l
16325.7
15799.5
0.03
28
155
(3004809) Band form neutrophils/100 leukocytes in Blood
27
138
1.98
2.77
5.0
3.9
%
1.0
1.4
0.34
21
118
(3003327) Ova and parasites identified in Stool by Light microscopy
42
248
1.72
2.76
1.7
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
53
334
1.62
2.74
2.6
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
240
2869
0.78
2.73
3.3
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
197
1.81
2.71
1.2
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
10
6.03
2.70
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
10
6.03
2.70
1.0
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
37
213
1.77
2.66
1.9
2.6
g/l
3.7
3.6
0.13
37
203
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
418
1.54
2.63
2.8
2.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
49
2.68
2.63
1.3
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
149
1.90
2.58
1.6
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
120
906
1.37
2.56
3.9
4.3
ug/l
8.2
25.9
1.08
102
752
(40760888) Immunoglobulin light chains.free panel - Serum
36
209
1.75
2.53
3.1
4.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
46
287
1.63
2.50
1.6
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
166
1.83
2.47
4.4
3.7
mmol/l
2.9
2.5
0.31
20
115
(3025130) Human papilloma virus identified in Specimen
17
76
2.26
2.45
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
96
2.11
2.44
1.4
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
33
189
1.77
2.44
1.4
1.7
iu/l
2.7
4.7
—
9
56
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
12
5.02
2.40
1.3
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
595
1.43
2.40
2.9
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
64
2.36
2.39
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
21
104
2.04
2.37
6.2
4.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
29
161
1.83
2.37
2.6
2.0
u/l
980.2
4143.3
—
8
56
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
22
111
2.00
2.37
1.4
1.2
u/ml
3.5
7.8
0.77
11
46
(3035637) Corticotropin [Mass/volume] in Plasma
18
84
2.16
2.36
1.1
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
71
2.27
2.35
1.4
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
292
1.60
2.35
2.5
2.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
32
184
1.76
2.34
2.6
2.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
253
2138
1.25
2.33
1.5
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
10
35
2.88
2.31
2.4
3.0
u/l
226.5
197.3
—
10
35
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
231
1.67
2.29
1.5
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
307
2654
1.23
2.29
4.5
4.8
ug/l
1.8
2.4
1.95
277
2370
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
310
1.58
2.29
4.0
2.4
g/l
3.1
3.1
0.02
38
243
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
72
2.24
2.28
1.0
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
28
156
1.82
2.27
1.7
1.3
mmol/l
57.0
61.9
0.22
21
132
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
13
4.64
2.27
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
49
320
1.56
2.23
2.0
1.9
—
—
—
0
0
(3013512) EKG study
290
2498
1.23
2.23
4.9
3.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
75
536
1.43
2.22
2.7
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
114
1.95
2.21
1.6
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
494
1.45
2.21
1.7
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
9
5.58
2.21
2.8
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
24
3.35
2.18
1.4
2.3
%
202.6
135.9
—
8
24
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
798
7601
1.26
2.18
6.5
5.9
mmol/mol
40.1
40.1
0.01
726
7034
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
108
1.96
2.16
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
30
174
1.75
2.15
1.2
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
21
109
1.95
2.11
1.3
1.2
u/ml
1.3
1.8
0.90
11
31
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
143
1141
1.30
2.11
1.6
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
255
2179
1.23
2.11
2.7
2.6
umol/l
2876.3
6577.4
1.10
221
1875
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
49
2.47
2.11
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
206
1.67
2.10
1.5
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
285
1.57
2.09
4.4
3.8
mg/l
25.8
41.9
0.81
30
230
(3016502) Oxygen saturation in Arterial blood
112
866
1.33
2.07
7.8
7.8
%
95.7
95.5
0.13
107
839
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
40
254
1.60
2.06
1.5
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
25
139
1.82
2.06
1.8
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
211
1771
1.24
2.06
4.2
4.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
69
2.19
2.05
1.1
1.1
u/ml
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
61
427
1.46
2.03
1.2
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
365
3242
1.20
2.02
4.4
3.7
ng/l
40.0
47.0
0.19
254
2317
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
83
2.07
2.02
1.1
1.3
e6/l
5468.3
222258.2
1.13
11
58
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
57
2.30
1.98
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
112
1.89
1.97
1.7
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
5
11
4.56
1.94
1.2
1.3
%
144.8
103.9
—
5
11
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
260
2245
1.21
1.93
1.7
1.6
mmol/l
1.4
1.4
0.27
215
1887
(3005322) IgE [Units/volume] in Serum or Plasma
67
483
1.42
1.92
1.2
1.3
u/ml
192.6
251.0
0.32
62
440
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.1
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
58
2.26
1.91
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
58
2.26
1.91
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
85
2.02
1.91
2.0
2.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
46
668
0.67
1.88
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
114
1.86
1.88
1.7
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
204
1723
1.23
1.87
1.8
1.7
pmol/l
93293143.1
16842539.4
0.57
164
1425
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
285
1.53
1.87
4.4
3.8
mg/l
90.4
70.9
0.12
30
229
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
190
1.65
1.86
1.6
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
40
2.52
1.84
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
40
2.52
1.84
1.4
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
12
4.18
1.82
1.0
1.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
32
199
1.63
1.82
1.6
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
132
1064
1.28
1.82
1.5
1.3
titre
570.4
521.7
0.10
27
232
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
131
1.77
1.78
1.1
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
84
638
1.35
1.78
2.4
3.0
g/l
9.7
10.7
1.47
76
585
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
330
1.48
1.78
3.9
2.4
g/l
3.8
3.8
0.03
38
238
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
330
1.48
1.78
4.0
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
330
1.48
1.78
4.0
2.4
g/l
7.2
7.4
0.25
40
250
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
41
2.45
1.76
2.1
3.2
u/ml
616.2
1148.7
—
10
41
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
87
666
1.34
1.75
2.7
2.9
ng/l
261.7
190.3
0.43
80
606
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
26
157
1.67
1.67
2.5
3.6
%
58.3
57.7
0.10
26
157
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
112
1.80
1.65
1.6
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
112
1.80
1.65
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
91
709
1.31
1.64
3.6
4.3
%
0.9
0.9
0.01
33
212
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
70
525
1.36
1.62
1.3
1.2
iu/ml
158.2
151.6
0.04
22
211
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
85
657
1.32
1.62
3.0
2.7
ml/min/173m2
68.4
64.9
0.39
39
270
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
113
1.79
1.61
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
151
1.67
1.61
1.9
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
43
2.34
1.60
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
63
2.08
1.60
1.2
1.1
—
—
—
0
0
(4268621)
14
70
2.01
1.59
2.6
2.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
43
297
1.47
1.58
1.9
1.7
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
26
2.70
1.58
1.6
1.1
ug/l
10.5
8.9
—
7
26
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
153
1.65
1.54
2.4
3.2
e9/l
4.1
4.3
0.13
25
153
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
33
2.44
1.54
2.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
33
2.44
1.54
2.0
2.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
20
115
1.75
1.53
3.9
2.1
u/ml
441.0
38.3
0.43
20
110
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
46
640
0.70
1.53
2.1
1.7
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
71
541
1.34
1.50
2.5
2.5
—
17.6
—
0
21
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
12
58
2.08
1.49
1.3
1.4
—
21.0
—
0
9
(3036603) Volume of Urine
13
65
2.01
1.49
1.9
1.4
ml
1912.0
1842.9
—
5
13
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
21
124
1.71
1.48
1.4
1.6
—
—
—
0
0
(3036489) Thrombin time
40
278
1.46
1.44
1.7
2.0
s
20.5
21.3
0.75
35
251
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
22
2.74
1.43
2.7
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
110
1.74
1.43
1.2
1.1
u/ml
0.3
2.1
—
6
42
(3021440) Promyelocytes/100 leukocytes in Blood
85
670
1.29
1.43
3.6
4.4
%
0.0
0.2
5.36
31
192
(3020630) Protein [Mass/volume] in Serum or Plasma
89
706
1.29
1.43
3.9
2.9
g/l
66.1
67.0
0.53
83
641
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
46
2.19
1.40
2.3
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
46
2.19
1.40
2.3
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
54
400
1.37
1.38
1.0
1.0
—
—
—
0
0
(4198724)
6
23
2.62
1.37
2.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
77
603
1.30
1.37
3.2
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
23
143
1.62
1.36
1.1
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
78
613
1.30
1.35
1.2
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
309
1.41
1.32
4.1
2.4
g/l
9.6
10.8
0.95
38
261
(3037756) Immunofixation for Serum or Plasma
29
193
1.52
1.30
1.6
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
34
2.36
1.29
2.0
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
34
2.36
1.29
1.1
9.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
25
2.41
1.24
3.0
2.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
36
2.23
1.24
1.0
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
85
684
1.27
1.24
5.3
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
243
2165
1.16
1.24
4.1
3.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
430
0.69
1.22
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
101
1.70
1.20
1.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
71
1.84
1.19
1.6
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
66
517
1.30
1.19
1.9
1.8
g/l
1.1
1.5
1.65
60
476
(3051611) Lipemic interference index of Serum or Plasma
15
86
1.76
1.19
2.3
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
173
1.52
1.19
4.5
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
87
1.74
1.15
7.1
3.9
%
54.4
50.9
—
9
66
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
24
158
1.53
1.15
1.8
1.9
pmol/l
169.6
211.1
1.26
24
147
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
20
2.51
1.15
4.0
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
191
1.48
1.15
2.0
2.1
g/l
136.1
131.2
0.41
18
146
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
95
1.70
1.14
1.0
1.1
u/ml
0.5
2.6
—
6
34
(3038177) Helicobacter pylori Ab [Presence] in Serum
17
103
1.66
1.13
1.2
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
82
666
1.25
1.12
4.6
3.7
mmol/l
1.2
1.2
0.85
70
583
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
33
234
1.42
1.12
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
127
1.59
1.12
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
31
2.27
1.10
1.0
1.4
—
—
—
0
0
(4306422)
17
104
1.65
1.10
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
54
418
1.31
1.08
4.5
3.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
32
2.20
1.08
1.1
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
74
1.77
1.07
1.1
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
52
1.93
1.06
2.7
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
52
1.93
1.06
3.9
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
263
1.38
1.05
1.6
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
154
1.51
1.04
1.3
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
46
1.97
1.03
1.2
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
9
46
1.97
1.03
1.4
1.4
u/l
11.7
14.6
—
9
41
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
98
1.64
1.03
1.0
1.0
u/ml
12.1
6.3
—
7
43
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
106
1.61
1.03
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
47
1.92
1.02
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
239
1.39
1.01
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
12
68
1.77
1.00
1.1
1.0
mg/l
288.7
298.3
0.19
12
58
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
56
441
1.29
1.00
9.0
10.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
48
1.88
1.00
2.2
3.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
1.6
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
49
1.84
0.98
1.6
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
215
1.41
0.98
1.9
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
5
23
2.18
0.98
2.2
1.3
mmol/l
1.5
2.5
—
5
23
(4062490)
12
69
1.75
0.96
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
33
242
1.38
0.95
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
51
1.77
0.94
4.2
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
217
1.39
0.94
1.4
1.2
u/ml
5.8
10.7
—
5
34
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
1.3
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
150
1.48
0.93
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
78
646
1.23
0.93
3.6
4.2
%
0.5
0.5
0.06
19
157
(3029937) Albumin [Presence] in Urine by Test strip
238
2161
1.13
0.93
4.5
4.1
estimate
0.0
0.0
0.88
84
737
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
79
656
1.22
0.92
4.1
3.7
ng/l
89.7
85.1
0.09
63
580
(4094501)
31
227
1.38
0.91
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
49
385
1.29
0.91
1.4
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
76
630
1.22
0.90
3.7
4.4
%
0.0
0.7
0.64
24
163
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
79
1.65
0.88
2.2
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
2.0
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
2.0
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
2.0
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
43
1.87
0.87
2.0
1.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
136
1.48
0.87
1.4
1.2
u/ml
533.5
303.5
0.53
14
80
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
32
238
1.36
0.87
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
145
1.46
0.85
1.3
1.2
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
22
308
0.71
0.84
3.8
4.0
mmol/l
1.8
1.3
0.63
22
301
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
24
171
1.41
0.83
2.0
3.6
u/ml
68.4
2143.0
0.81
24
163
(3009343) pH of Capillary blood
68
563
1.22
0.83
5.4
3.3
ph
7.4
7.4
—
8
81
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
842
8239
1.15
0.83
5.6
5.1
mmol/l
2.8
2.8
0.69
762
7545
(3020961) Endomysium IgA Ab [Titer] in Serum
45
355
1.28
0.83
1.0
1.1
—
167.3
—
0
7
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
46
1.75
0.82
1.0
1.1
u/l
70.2
88.2
—
8
35
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
46
1.75
0.82
1.0
1.1
u/l
33.9
28.8
—
8
34
(3021901) Oxygen saturation in Capillary blood
23
163
1.42
0.82
3.6
2.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
32
1.88
0.82
1.2
3.5
—
63687.9
—
0
7
(40765096) Chromosome analysis panel by Banding
6
32
1.88
0.82
1.3
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
199
1.37
0.79
1.5
1.4
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
15
98
1.54
0.78
1.4
1.4
g/l
30.2
32.1
0.26
15
84
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
44
349
1.27
0.78
2.2
1.9
ug/l
1.8
2.2
0.09
36
312
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
123
1.47
0.78
1.3
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
1630.5
—
0
27
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
27
200
1.36
0.77
1.4
1.3
miu/ml
156.9
237.8
0.57
14
89
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
59
1.70
0.76
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
50
406
1.24
0.74
5.7
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
330
3091
1.10
0.74
4.6
4.0
—
—
—
0
0
(3020891) Body temperature
25
333
0.74
0.73
4.0
4.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
9
56
1.61
0.72
1.9
2.2
ug/l
1.4
3.6
—
9
49
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
60
1.67
0.72
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
41
1.71
0.70
28.4
19.1
nmol/l
1615.7
1602.0
—
7
41
(3051651) Icteric interference index of Serum or Plasma
9
58
1.56
0.70
1.7
3.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
204
1.33
0.69
1.4
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
64
539
1.20
0.69
5.5
3.3
mmol/l
1.9
1.9
0.04
48
416
(3019832) Treponema pallidum Ab [Presence] in Serum
59
493
1.21
0.69
1.6
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
43
347
1.25
0.69
3.8
3.3
u/ml
256.4
4034.7
0.72
38
298
(3024471) HLA-A [Type]
5
27
1.86
0.68
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
59
1.53
0.68
1.6
1.5
—
—
—
0
0
(1002224) Polysomnography panel
43
349
1.24
0.66
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
819
8028
1.12
0.66
5.0
4.5
mmol/l
1.5
1.5
0.40
739
7350
(40767503) Oxygen content in Capillary blood by calculation
24
180
1.34
0.65
2.8
2.4
%
19.0
16.4
—
10
102
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
230
2129
1.10
0.65
3.7
4.2
%
20.0
21.3
0.62
89
998
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
233
1.30
0.65
1.6
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
19
137
1.39
0.65
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
156
1415
1.12
0.64
1.3
1.3
iu/ml
37.4
34.6
0.10
49
464
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
127
0.63
0.64
1.0
1.1
—
155.5
—
0
24
(3017704) Immunofixation for Urine
8
49
1.64
0.62
2.6
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
13
88
1.48
0.60
1.5
1.3
e6/l
1046.8
1838.5
—
8
60
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
823
8080
1.11
0.60
5.1
4.5
mmol/l
4.7
4.7
0.28
749
7450
(3019150) Specific gravity of Urine by Refractometry
192
1771
1.10
0.59
3.9
4.1
kg/l
1.0
1.0
0.08
23
241
(3045424) Erythrocytes [Presence] in Urine
19
140
1.36
0.58
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
170
1559
1.11
0.58
2.7
2.9
ug/l
0.7
0.7
0.71
116
1022
(3010726) Horse dander IgE Ab [Units/volume] in Serum
13
89
1.47
0.58
1.1
1.0
—
3.9
—
0
20
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
116
0.60
0.57
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
27
211
1.29
0.57
2.0
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
158
1.34
0.57
2.1
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
274
1.25
0.57
2.6
1.8
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
81
1.49
0.57
1.6
1.3
e6/l
33820.0
48941.8
—
6
46
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
98
1.43
0.56
1.8
2.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
88
0.57
0.56
2.0
1.5
—
—
—
0
0
(44813793)
8
55
1.46
0.56
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
27
212
1.28
0.56
2.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
37
1.63
0.55
1.5
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
37
1.63
0.55
1.2
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
116
1.39
0.54
2.9
2.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
99
1.42
0.54
1.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
14
99
1.42
0.54
1.0
1.3
nmol/l
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
11
74
1.49
0.53
1.5
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
63
1.43
0.52
2.2
1.7
%
12.0
10.7
—
9
63
(3037121) Protein [Mass/volume] in Urine
35
287
1.23
0.52
4.3
3.3
g/l
0.4
0.2
0.72
17
113
(3000012) Reticulocyte production index
6
40
1.50
0.51
1.7
2.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
29
236
1.24
0.47
1.1
1.2
—
1207.1
—
0
7
(3000764) Benzodiazepines [Presence] in Urine
26
209
1.25
0.47
2.1
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
81
0.62
0.46
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
24
192
1.26
0.45
2.0
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
50
1.40
0.45
2.9
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
50
1.40
0.45
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
51
1.38
0.44
1.6
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
26
211
1.24
0.44
1.5
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
14
104
1.35
0.43
1.6
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
78
1.41
0.43
1.5
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
33
1.52
0.41
23.6
31.2
ug/l
7.4
7.1
—
5
28
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
50.4
—
0
10
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.2
—
1.9
—
0
15
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.2
—
39.7
—
0
6
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
2.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
144
1339
1.09
0.40
1.2
1.3
u/ml
1.8
14.0
7.47
34
516
(44790047)
13
97
1.34
0.39
1.2
1.5
—
—
—
0
0
(44790048)
13
97
1.34
0.39
1.2
1.5
—
—
—
0
0
(44806118)
13
97
1.34
0.39
1.2
1.5
—
—
—
0
0
(44790049)
13
97
1.34
0.39
1.2
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
106
1.33
0.39
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
36
1.39
0.38
1.8
1.1
mmol/l
5.9
6.5
—
5
36
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
9
68
1.33
0.37
1.0
1.0
—
0.7
—
0
16
(3011288) Drugs identified in Urine by Screen method
17
134
1.27
0.37
2.4
2.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
70
1.29
0.36
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
71
1.27
0.36
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
217
1.20
0.35
2.7
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
46
404
1.15
0.35
5.2
3.4
%
47.8
48.6
0.07
46
399
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
25
208
1.21
0.35
2.2
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
123
0.73
0.35
1.3
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
73
1.37
0.34
3.5
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
45
1.34
0.33
1.0
1.3
nmol/l
131.7
156.1
—
6
45
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
136
1.25
0.33
1.4
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
112
1041
1.09
0.33
7.6
7.2
—
—
—
0
0
(3019977) pH of Arterial blood
6
46
1.31
0.33
2.3
4.1
—
7.4
—
0
16
(3047189) Immunofixation for 24 hour Urine
6
46
1.31
0.33
4.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
209
0.81
0.32
1.3
1.3
mg/l
576.5
518.4
0.20
17
195
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
74
1.35
0.32
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
40
351
1.15
0.32
2.4
2.1
u/l
40.8
40.5
0.03
35
307
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.8
1.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.0
ng/l
169.0
332.7
—
7
30
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
7
52
1.35
0.31
1.1
1.0
ng/l
14.7
51.0
—
7
28
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.0
ng/l
849.9
635.4
—
7
30
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
54
1.30
0.30
2.4
1.4
g/l
0.9
1.0
—
7
54
(3016018) Differential panel - Cerebral spinal fluid
10
75
1.34
0.30
1.4
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
80
738
1.09
0.29
2.3
2.5
ug/l
8.7
7.0
0.27
65
648
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
158
1.21
0.28
2.2
1.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
85
1.30
0.28
1.8
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
122
1.23
0.27
1.4
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
258
2487
1.05
0.27
3.6
3.2
mg/l
313.2
251.8
0.09
165
1580
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
67
1.20
0.26
1.1
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.8
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
77
1.30
0.26
1.8
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
5
72
0.69
0.26
1.2
1.2
nmol/l
1.2
1.4
—
5
64
(3032773) Endomysium IgG Ab [Titer] in Serum
9
74
1.22
0.25
1.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
96
1.25
0.24
1.0
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
85
0.70
0.24
3.7
2.1
%
13.2
13.2
—
6
85
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
199
1.16
0.23
1.3
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
270
2616
1.04
0.23
3.6
3.1
mmol/l
7.3
7.5
0.31
226
2200
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
38
1.32
0.23
1.6
1.7
ug/l
67.8
53.8
—
5
38
(3035880) pH of Pleural fluid
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(4034850)
29
257
1.13
0.22
9.8
10.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
41
1.22
0.22
1.2
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
2.6
—
0.6
—
0
11
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
2.8
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
145
1.18
0.20
1.4
1.7
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
6.5
—
0
14
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
6
48
1.25
0.20
1.5
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
51
1.18
0.19
1.3
1.3
u/l
4.8
6.5
—
6
39
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
118
1.19
0.19
5.3
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
782
7753
1.04
0.19
4.5
4.1
mmol/l
1.4
1.3
1.14
701
7058
(3051387) C reactive protein [Mass/volume] in Capillary blood
22
194
1.14
0.18
4.4
3.6
mg/l
37.6
24.9
0.67
17
121
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
59
1.19
0.18
1.3
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
119
1.18
0.17
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
119
1.18
0.17
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
247
0.89
0.17
1.8
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
70
1.14
0.16
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
16
139
1.15
0.16
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
111
1065
1.05
0.16
4.8
4.5
%
32.1
32.5
0.11
68
707
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
149
1.14
0.15
4.2
3.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
9
79
1.14
0.15
1.1
1.0
—
1.8
—
0
29
(40761535) Cells panel - Urine sediment
73
693
1.06
0.15
3.7
3.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
84
1.19
0.14
1.4
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
263
0.91
0.13
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
268
2627
1.03
0.13
4.7
4.0
mg/mmol
17.1
8.1
0.61
173
1656
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
88
845
1.05
0.13
1.7
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
56
588
0.95
0.11
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
44
1.14
0.10
5.2
2.1
e6/l
732.8
639.9
—
5
39
(3045142) Bone marrow Pathology biopsy report
12
106
1.13
0.10
1.4
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
46
1.09
0.09
1.2
1.3
ug/l
0.9
2.8
—
5
37
(3019060) Gas panel - Arterial blood
58
558
1.04
0.08
4.1
4.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
17
156
1.09
0.08
1.8
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
80
0.87
0.07
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
80
0.87
0.07
1.0
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
82
0.85
0.07
1.0
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
245
1.06
0.07
1.7
1.6
iu/ml
0.3
0.1
—
9
39
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
84
1.07
0.07
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
87
1.03
0.07
1.9
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
88
1.02
0.07
1.2
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
103
0.87
0.06
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
109
1.10
0.06
1.8
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
10
91
1.10
0.04
1.1
1.3
—
—
—
0
0
(4281824)
10
91
1.10
0.04
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
39
402
0.97
0.04
4.6
3.5
u/ml
18.8
54.2
2.25
39
387
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
119
0.92
0.04
1.1
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
17
179
0.95
0.03
1.4
1.2
e6/l
1.2
32.8
—
9
141
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
17
179
0.95
0.03
1.5
1.3
e6/l
2736.3
794.7
0.30
11
144
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
102
1.08
0.03
1.1
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
231
1.04
0.02
7.9
4.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
162
1.05
0.02
1.4
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
293
1.02
0.01
1.5
1.8
mg/l
3.4
5.0
0.34
22
231
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
186
0.97
0.00
1.4
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
164
0.98
0.00
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
362
0.99
0.00
1.6
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
18
177
1.02
0.00
1.3
1.8
nmol/l
0.8
0.9
0.24
13
150
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
21
215
0.98
0.00
1.3
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
15
155
0.97
0.00
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
205
0.98
0.00
1.9
2.5
ug/min
24.7
86.9
2.08
11
122
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
95
1.05
0.00
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
72
0.97
0.00
1.1
1.0
—
—
—
0
0
(4024509)
7
72
0.97
0.00
1.7
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
52
0.96
0.00
2.6
3.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
8.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.7
—
0
7
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(4146454)
9
96
0.94
0.00
2.8
2.7
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
330.6
—
0
5
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
5.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
84
0.95
0.00
1.5
2.1
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
15.8
—
0
6
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
49
1.02
0.00
1.2
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
7
71
0.99
0.00
3.7
1.7
—
2.2
—
0
29
(21494890) Protein electrophoresis panel - 24 hour Urine
9
92
0.98
0.00
4.7
2.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
79
1.01
0.00
1.5
1.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_TONGUE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_TONGUE | 1.22 [1.08, 1.38] | 0.002 |
| Birth year | 1.0 [0.99, 1.01] | 0.949 |
During the follow-up period (1.1.1998 — 31.12.2019), 623 out of 3101 females with CD2_BENIGN_TONGUE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_TONGUE | 1.408 [1.23, 1.62] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 571 out of 2502 males with CD2_BENIGN_TONGUE died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_TONGUE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.245% |
| 5 | 0.783% | 1.485% |
| 10 | 2.157% | 3.893% |
| 15 | 4.34% | 7.444% |
| 20 | 7.575% | 12.598% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_TONGUE – Benign neoplasm: Tongue
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data